Anthropometric Characteristics, Passive Hip Flexion, and Spinal Mobility in Relation to Back Pain in Athletes

Spine ◽  
1990 ◽  
Vol 15 (5) ◽  
pp. 376-382 ◽  
Author(s):  
LEIF SWÄRD ◽  
BENGT ERIKSSON ◽  
LARS PETERSON
Keyword(s):  
Back Pain ◽  
Spinal Mobility ◽  
Anthropometric Characteristics ◽  
Hip Flexion

scholarly journals AB0493 WHAT IS THE DIAGNOSTIC VALUE OF IMPAIRED SPINAL MOBILITY MEASUREMENTS IN INFLAMMATORY BACK PAIN PATIENTS? DATA FROM THE DESIR COHORT

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1273.2-1274
Author(s):  
C. Lukas ◽  
G. Khoury ◽  
M. A. D’agostino ◽  
B. Combe ◽  
J. Morel
Keyword(s):  
Back Pain ◽  
General Population ◽  
Diagnostic Value ◽  
Spinal Mobility ◽  
Inflammatory Back Pain ◽  
Mobility Impairment ◽  
Research Support ◽  
Predictive Values ◽  
Asas Criteria

Background:The diagnostic process in a patient with early inflammatory back pain suggestive of axial spondyloarthritis (ax-SpA) requires assessment and integration of multiple aspects, including clinical examination, biological measurements and radiologic assessments. Among the physical examination features, alteration of spinal mobility is often observed in ax-SpA. However, whether mobility impairment might really increase diagnostic likelihood, and which of the measurements made have relevant diagnostic value remains unknown.Objectives:To describe the frequency and severity of mobility impairment in multiple traditional measurements in patients suspect of early ax-SpA at initial assessment time, and to analyze their individual diagnostic performances in reference to usual classification criteria applied after 2 years of follow-up.Methods:Data from the DESIR cohort, which included patients aged 18-50 with inflammatory back pain lasting for 3 months to 3 years and a clinical suspicion of ax-SpA diagnosis were used. Baseline measurements of Schober’s test (Schober), chest expansion (CEx), lateral spinal flexion (LatSpiFlex), cervical rotation (CervRot) and intermalleolar distance (IntMalDist) collected at baseline were classified according to reference data from the general population adjusted for age and -when appropriate- for height. Cutoffs were defined as above 2.5th, 5th, 10th and 25th percentiles. With ASAS classification for ax-SpA applied at 2 years follow-up visit as external reference, diagnostic performances (Sensitivity [Se], Specificity [Sp], Positive [PPV] and Negative [NPV] Predictive Values) were calculated.Results:Complete data were available for 575 patients (of whom 377 (66%) fulfilled the ASAS criteria at 2 years). Schober, CEx, LatSpiFlex, CervRot and IntMalDist were above 5th percentile in respectively 278 (48%), 82 (14%), 220 (38%) and 93 (16%) patients. None of the measurements showed a clinically relevant compromise between both Se and Sp, but Sp was highest for CEx-most impaired cutoffs (Figure 1). The highest PPV (73.6%) and NPV (39.4%) were observed for LatSpiFlex.Conclusion:Measures of mobility and their levels of impairment do not show sufficient individual diagnostic value for ax-SpA among patients with early inflammatory back pain. However, highest degrees of impairment when compared to general population are more specifically observed in patients finally classified with ax-SpA for CEx, which was –consistently- 1 of the 2 mobility measures that was retained in the modified New York criteria for ankylosing spondylitis.Disclosure of Interests:Cédric Lukas Speakers bureau: AbbVie; Lilly; Merck; Novartis; Pfizer; Roche-Chugai;, Consultant of: AbbVie; Bristol-Myers Squibb; Janssen; Lilly; Merck; Novartis; Pfizer; Roche-Chugai; UCB; Sanofi;, Grant/research support from: Pfizer: Novartis, Gisèle Khoury Grant/research support from: Pfizer, Maria-Antonietta d’Agostino: None declared., Bernard Combe Speakers bureau: AbbVie; Bristol-Myers Squibb; Gilead; Janssen; Lilly; Merck; Novartis; Pfizer; Roche-Chugai; and Sanofi, Consultant of: AbbVie; Bristol-Myers Squibb; Gilead; Janssen; Lilly; Merck; Novartis; Pfizer; Roche-Chugai; and Sanofi, Grant/research support from: Novartis, Pfizer, and Roche-Chugai, Jacques Morel Speakers bureau: AbbVie; Bristol-Myers Squibb; Gilead; Janssen; Lilly; Merck; Novartis; Pfizer; Roche-Chugai; and Sanofi, Consultant of: AbbVie; Bristol-Myers Squibb; Gilead; Janssen; Lilly; Merck; Novartis; Pfizer; Roche-Chugai; and Sanofi, Grant/research support from: Novartis, Pfizer, and Roche-Chugai.

scholarly journals Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis

2018 ◽  
Vol 45 (12) ◽  
pp. 1643-1650 ◽  
Author(s):  
Camilla Fongen ◽  
Hanne Dagfinrud ◽  
Inger Jorid Berg ◽  
Sofia Ramiro ◽  
Floris van Gaalen ◽  
...  
Keyword(s):  
Back Pain ◽  
Chronic Back Pain ◽  
Axial Spondyloarthritis ◽  
Spinal Mobility ◽  
Chest Expansion ◽  
Wall Distance ◽  
Intermalleolar Distance ◽  
Cervical Rotation ◽  
Mobility Measure ◽  
Spinal Flexion

Objective.To examine the frequency of impaired spinal mobility in patients with chronic back pain of short duration and to compare it with the frequency of impaired spinal mobility in patients with axial spondyloarthritis (axSpA), possible SpA, and no SpA.Methods.The SpondyloArthritis Caught Early (SPACE) cohort includes patients with chronic back pain (≥ 3 mos, ≤ 2 yrs, onset < 45 yrs). Spinal mobility was assessed with lateral spinal flexion, chest expansion, cervical rotation, occiput-to-wall distance, and lumbar flexion. Hip mobility was assessed with intermalleolar distance. Mobility measures were defined as impaired if below the 5th percentile reference curve from general population, adjusted for age and height when appropriate. Proportions of patients categorized with impaired mobility were examined with chi square.Results.In total, 393 patients with chronic back pain were included: 142 axSpA, 140 possible SpA, and 111 no SpA. Impairment in ≥ 1 mobility measure was present in 66% of all patients. The most frequently impaired mobility measure was lateral spinal flexion (40%), followed by chest expansion (22%), cervical rotation (18%), intermalleolar distance (17%), lumbar flexion (15%), and occiput-to-wall distance (11%). No statistically significant differences in proportion of patients with impaired spinal mobility were found between patients with axSpA and the other subgroups in any of the tests.Conclusion.Two out of 3 patients with chronic back pain of short duration had impaired spinal mobility compared to the general population. Impaired spinal mobility occurs as often in patients with early axSpA as in other forms of chronic back pain.

scholarly journals Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort

Rheumatology ◽  
2020 ◽  
Vol 60 (1) ◽  
pp. 316-321
Author(s):  
Fumio Hirano ◽  
Désirée van der Heijde ◽  
Floris A van Gaalen ◽  
Robert B M Landewé ◽  
Cécile Gaujoux-Viala ◽  
...  
Keyword(s):  
Back Pain ◽  
Educational Level ◽  
Joint Pain ◽  
Structural Damage ◽  
Axial Spondyloarthritis ◽  
Morning Stiffness ◽  
Well Being ◽  
Spinal Mobility ◽  
Explanatory Variables ◽  
Over Time

Abstract Objectives To investigate the determinants of patient well-being over time, and the influence of age, gender and education in patients with early axial spondyloarthritis (axSpA). Methods Five-year data from DESIR, a cohort of early axSpA, were analysed. The outcome was the BAS-G over 5 years. Generalized estimating equations (GEE) were used to test the relationship between potential explanatory variables from five outcome domains (disease activity, physical function, spinal mobility, structural damage and axial inflammation) and BAS-G over time. Longitudinal relationships were analysed using an autoregressive GEE model. Age, gender and educational level were tested as effect modifiers or confounders. Results A total of 708 patients were included. Higher BASDAI questions on fatigue [β (95% CI): 0.17 (0.13, 0.22)], back pain [0.51 (0.46, 0.56)], peripheral joint pain [0.08 (0.04, 0.12)] and severity of morning stiffness [0.08 (0.03–0.13)], and higher BASFI [0.14 (0.08, 0.19)] were associated with a higher BAS-G. In the autoregressive model, the same variables except for morning stiffness were associated with a worsening in BAS-G. Age, gender and educational level were neither effect modifiers nor confounders. Conclusion A higher level of back pain is associated with a worsening of patient well-being, as are, though to a lesser extent, higher levels of fatigue, peripheral joint pain and physical disability. Age, gender and educational level do not have an impact on these relationships.

Effects of Spinal Flexion and Extension Exercises on Low-Back Pain and Spinal Mobility in Chronic Mechanical Low-Back Pain Patients

Spine ◽  
1991 ◽  
Vol 16 (8) ◽  
pp. 967-972 ◽  
Author(s):  
IBRAHIM MAGDY ELNAGGAR ◽  
MARGARETA NORDIN ◽  
ALI SHEIKHZADEH ◽  
MOHAMAD PARNIANPOUR ◽  
NEIL KAHANOVITZ
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Spinal Mobility ◽  
Low Back ◽  
Pain Patients ◽  
Flexion And Extension ◽  
Spinal Flexion

scholarly journals Effects of myofascial techniques on pain, mobility and function in patients with low back pain: a double-blind, controlled and randomized trial

2020 ◽  
Vol 18 ◽  
pp. 1-6
Author(s):  
Fabiana Forti Sakabe ◽  
Danielle Audickas Mazer ◽  
Julia Alves Cia ◽  
Daniel Iwai Sakabe ◽  
Gustavo Luiz Bortolazzo
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Pain Intensity ◽  
Treatment Protocol ◽  
Spinal Mobility ◽  
Iliopsoas Muscle ◽  
Control Group ◽  
Low Back ◽  
Chain Flexibility ◽  
Quadratus Lumborum

Introduction: Low back pain is one of the most frequent causes of disability, with several associated etiologies. Osteopathic manipulative treatment is widely used to evaluate and manage musculoskeletal disorders. The aim of the study was to evaluate the immediate and late effects of 3 sessions of myofascial osteopathic techniques on pain intensity, posterior chain flexibility, lumbar mobility and level of disability in patients with chronic low back pain. Methods: 60 subjects of both genders, randomly divided into 3 experimental groups: healthy control (HC n = 20), low back pain control group (CG, n = 20) and treated low back pain group (TG, n = 20). Initially, the 3 groups were evaluated using the Visual Analogue Scale (VAS), Oswestry questionnaire, Wells bench and measurement of lateral spine tilt and fingertip-to-floor test. The TG was submitted to 3 sessions of myofascial techniques (lasting 40 minutes), 1x / week. The session consisted of the application of 6 myofascial techniques (thoracolumbar fascia, quadratus lumborum fascia, iliopsoas muscle stretching, quadratus lumborum stretching and iliolumbar ligaments). Subjects were reevaluated immediately after the first session, 7 days after the last session and one month after treatment completion (follow up). Results: There was an improvement in posterior chain flexibility (20.3 ± 7.4 cm pre to 26.3 ± 8 cm after 3 sessions), spinal mobility (fingertip-to-floor: 13.3 ± 11.33 cm pre to 4.8 ± 10.5 cm after 3 sessions), as well as pain intensity reduction (3.3 ± 1.9 cm pre to 1 ± 1.7 after 3 sessions) and reduction in the level of lumbar disability (15.8 ± 7.3 in the pre to 9.2 ± 8.6 after 3 sessions) for TG. In HC and CG there was no change in any of the variables. The results shown for TG remained even one month after the intervention. Conclusion: The osteopathic treatment protocol with myofascial techniques was effective for the treatment of low back pain.

scholarly journals Correlation of spinal mobility with the severity of chronic lower back pain

1995 ◽  
Vol 36 (1) ◽  
pp. 37 ◽  
Author(s):  
Seong Woong Kang ◽  
Woong Nam Lee ◽  
Jae Ho Moon ◽  
Sae Il Chun
Keyword(s):  
Back Pain ◽  
Lower Back Pain ◽  
Spinal Mobility ◽  
Chronic Lower Back Pain ◽  
Lower Back

scholarly journals Hip–spine syndrome: rationale for ischiofemoral impingement, femoroacetabular impingement and abnormal femoral torsion leading to low back pain

2020 ◽  
Author(s):  
Anthony N Khoury ◽  
Munif Hatem ◽  
Joshua Bowler ◽  
Hal David Martin
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Femoroacetabular Impingement ◽  
Hip Osteoarthritis ◽  
Low Back ◽  
Femoral Torsion ◽  
Hip Range Of Motion ◽  
Flexion Extension ◽  
Hip Flexion ◽  
Ischiofemoral Impingement

Abstract The term ‘hip–spine syndrome’ was introduced in recognition of the frequent occurrence of concomitant symptoms at the hip and lumbar spine. Limitations in hip range of motion can result in abnormal lumbopelvic mechanics. Ischiofemoral impingement, femoroacetabular impingement and abnormal femoral torsion are increasingly linked to abnormal hip and spinopelvic biomechanics. The purpose of this narrative review is to explain the mechanism by which these three abnormal hip pathologies contribute to increased low back pain in patients without hip osteoarthritis. This paper presents a thorough rationale of the anatomical and biomechanical characteristics of the aforementioned hip pathologies, and how each contributes to premature coupling and limited hip flexion/extension. The future of hip and spine conservative and surgical management requires the implementation of a global hip–spine–pelvis-core approach to improve patient function and satisfaction.

Measurement error associated with spinal mobility measures in children with and without low-back pain

2007 ◽  
Vol 91 (12) ◽  
pp. 1339-1343 ◽  
Author(s):  
MA Jones ◽  
G Stratton ◽  
T Reilly ◽  
VB Unnithan
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Measurement Error ◽  
Spinal Mobility ◽  
Low Back
Sign in / Sign up

Export Citation Format

Share Document